Sofia, Bulgaria, March 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for February 2023 the Company recorded an increase in sales of 20% compared to the same month of the previous year, incl. 41% increase in domestic sales and 10% increase in export sales.

For the first two months of 2023, sales increased by a total of 21%, incl. same level of domestic sales and 42% increase in export sales.